Elicera Therapeutics AB (ELIC) — Free Cash Flow Generation Index
Latest as of December 2023:
1.00x
Elicera Therapeutics AB (ELIC) has a Free Cash Flow Generation Index of 1.00x as of December 2023. Free cash flow of Skr3.50 Million represents 1% of operating cash flow (Skr3.50 Million). See Elicera Therapeutics AB working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
1.00x
Free Cash Flow / Operating CF
Free Cash Flow
Skr3.50 Million
SEK
Operating Cash Flow
Skr3.50 Million
SEK
Capital Expenditures
Skr1.00K
SEK
Annual Free Cash Flow Generation for Elicera Therapeutics AB (None–None)
Year-by-year Free Cash Flow Generation Index for Elicera Therapeutics AB. For the full company profile including market capitalisation, see ELIC company net worth.
| Year | FCG Index | Free Cash Flow (SEK) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).